Mitchell S Cairo Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

1/2019	Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
4/2013	Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell S Cairo Research Topics

Disease

44	Neoplasms (Cancer) 01/2023 - 02/2003
24	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 02/2003
24	Lymphoma (Lymphomas) 01/2022 - 02/2003
22	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 03/2002
20	Leukemia 01/2023 - 10/2005
20	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 03/2002
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 03/2002
14	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2024 - 10/2005
11	Hematologic Neoplasms (Hematological Malignancy) 09/2021 - 12/2002
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 07/2004
8	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 09/2011
8	Infections 01/2021 - 04/2003
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015 - 09/2008
7	Tumor Lysis Syndrome 11/2023 - 12/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 02/2012
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2004
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020 - 04/2010
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 12/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 03/2002
5	Bronchiolitis Obliterans Syndrome 05/2015 - 04/2004
5	Thrombocytopenia (Thrombopenia) 01/2007 - 05/2002
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 04/2005
4	Residual Neoplasm 01/2023 - 12/2004
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 04/2005
4	Hyperuricemia 01/2017 - 12/2002
3	Neutropenia 10/2023 - 10/2005
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2010
3	Pathologic Complete Response 01/2020 - 02/2012
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019 - 02/2010
3	Hemoglobinopathies 11/2017 - 04/2011
3	Central Nervous System Diseases (CNS Diseases) 08/2015 - 04/2007
3	Hemolysis 05/2015 - 08/2007
3	Sepsis (Septicemia) 12/2014 - 01/2002
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 02/2008
3	Skin Diseases (Skin Disease) 03/2014 - 04/2010
3	Neonatal Sepsis 01/2005 - 01/2002
2	Virus Diseases (Viral Diseases) 01/2023 - 12/2019
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Multiple Myeloma 09/2021 - 10/2008
2	Hemorrhage 01/2021 - 05/2002
2	Wounds and Injuries (Trauma) 01/2020 - 03/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2013
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

19	Rituximab (Mabthera)FDA Link 01/2022 - 09/2003
8	rasburicase (Elitek)FDA Link 01/2017 - 12/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 09/2003
7	CytokinesIBA 01/2023 - 10/2009
7	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2007
7	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2005
6	Monoclonal AntibodiesIBA 09/2021 - 08/2008
5	Chimeric Antigen ReceptorsIBA 10/2020 - 09/2014
5	AntigensIBA 01/2019 - 03/2002
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 04/2004
5	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 02/2007
5	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 01/2005
5	Ifosfamide FDA LinkGeneric 01/2015 - 01/2005
5	HLA Antigens (Human Leukocyte Antigens)IBA 04/2011 - 03/2002
5	Interleukin-11 (Interleukin 11)IBA 01/2007 - 05/2002
4	Uric Acid (Urate)IBA 11/2023 - 12/2002
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 04/2004
4	Collagen Type VIIIBA 01/2018 - 04/2010
4	Allopurinol (Remid)FDA LinkGeneric 01/2017 - 12/2002
4	IceIBA 01/2015 - 01/2005
4	Prednisone (Sone)FDA LinkGeneric 03/2012 - 09/2003
3	Alemtuzumab (Campath)FDA Link 10/2023 - 01/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 06/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2022 - 02/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2011
3	obinutuzumabIBA 08/2020 - 12/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 04/2007
3	Gemtuzumab (Mylotarg)FDA Link 04/2016 - 10/2005
3	InterleukinsIBA 12/2014 - 01/2007
3	Vincristine (Oncovin)FDA LinkGeneric 03/2012 - 04/2007
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2012 - 10/2008
3	ParaffinIBA 10/2008 - 05/2003
2	Ganciclovir (Cytovene)FDA LinkGeneric 10/2023 - 09/2007
2	KIR ReceptorsIBA 01/2023 - 10/2007
2	Peptides (Polypeptides)IBA 01/2023 - 01/2020
2	CollagenIBA 01/2023 - 01/2018
2	ibrutinibIBA 09/2022 - 01/2019
2	ruxolitinibIBA 09/2022 - 02/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2006
2	LigandsIBA 01/2021 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2014
2	Granzymes (Granzyme)IBA 02/2017 - 10/2009

Therapy/Procedure

41	Therapeutics 01/2023 - 02/2003
33	Transplantation 01/2021 - 03/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
26	Stem Cell Transplantation 10/2023 - 04/2002
23	Cell Transplantation 12/2022 - 02/2008
19	Immunotherapy 01/2023 - 04/2003
15	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2004
10	Homologous Transplantation 01/2021 - 04/2006
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 03/2002
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2010
2	Donor Selection 01/2023 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 08/2020 - 03/2012
2	Aftercare (After-Treatment) 12/2017 - 11/2014
2	Length of Stay 01/2017 - 02/2008